Enhanced tumor immunohistochemical detection using a protein A-fused Pyrococcus furiosus ferritin carrier with drastically reduced antibody amount

Area of Science:

• Biotechnology
• Molecular Pathology
• Nanotechnology

Background:

• Immunohistochemistry (IHC) is crucial for tumor pathology but struggles with detecting low-abundance antigens due to high antibody requirements.
• High antibody input in IHC increases costs and limits analytical efficiency, hindering sensitive biomarker detection.

Purpose of the Study:

• To develop a novel ferritin-based nanocarrier system for enhanced IHC signal amplification.
• To improve the detection sensitivity of weakly expressed tumor markers while reducing antibody consumption.

Main Methods:

• Genetically fused Protein A to Pyrococcus furiosus ferritin (PA-PfFn) to create a multivalent scaffold.
• Utilized the PA-PfFn scaffold for Fc-directed recruitment of HRP-conjugated secondary antibodies.
• Tested the PA-PfFn-HRP polymer system in a mouse glioma (U87) model.

Main Results:

• The PA-PfFn-HRP polymer significantly amplified detection signals through avid binding and enzymatic cascade reactions.
• Achieved higher detection sensitivity compared to conventional IHC in a mouse glioma model.
• Maintained robust staining performance with primary antibody concentrations reduced by up to 128-fold.

Conclusions:

• The novel ferritin-based nanocarrier system provides a practical and cost-effective approach for sensitive tumor biomarker detection.
• This modular and tunable platform enables robust visualization of weakly expressed tumor markers.
• Offers potential for quantitative pathological analysis in clinical and translational research settings.